School of Medicine and Medical Science, University College Dublin, Dublin, Ireland.
AJR Am J Roentgenol. 2011 Aug;197(2):367-73. doi: 10.2214/ajr.10.4569.
The purpose of this study was to prospectively evaluate the effect of cranial breast displacement and lead shielding on in vivo breast surface radiation dose in women undergoing coronary CT angiography.
Fifty-four women (mean age, 59.2 ± 9.8 years) prospectively underwent coronary 64-MDCT angiography for evaluation of chest pain. The patients were randomly assigned to a control group (n = 16), breast displacement group (n = 22), or breast displacement plus lead shielding group (n = 16). Thermoluminescent dosimeters (TLDs) were placed superficially on each breast quadrant and the areolar region of both breasts. Breast surface radiation doses, the degree of breast displacement, and coronary image quality were compared between groups. A phantom dose study was conducted to compare breast doses with z-axis positioning on the chest wall.
A total of 1620 TLD dose measurements were recorded. Compared with control values, the mean breast surface dose was reduced 23% in the breast displacement group (24.3 vs 18.6 mGy, p = 0.015) and 36% in the displacement plus lead shielding group (24.3 vs 15.6 mGy, p = 0.0001). Surface dose reductions were greatest in the upper outer (displacement alone, 66%; displacement plus shielding, 63%), upper inner (65%, 58%), and areolar quadrants (44%, 53%). The smallest surface dose reductions were recorded for A-cup breasts: 7% for the displacement group and 3% for the displacement plus lead group (p = 0.741). Larger reductions in surface dose were recorded for B-cup (25% and 56%, p = 0.273), C-cup (38% and 60%, p = 0.001), and D-cup (31% and 25%, p = 0.095) sizes. Most of the patients (79%) had either good (< 50% of breast above scan range) or excellent (< 75% of breast above the scan range) breast displacement. No significant difference in coronary image quality was detected between groups. The phantom dose study showed that surface TLD measurements were underestimates of absorbed tissue dose by a mean of 9% and that a strong negative correlation exists between the amount of cranial displacement and breast dose.
Use of breast displacement during coronary CTA substantially reduces the radiation dose to the breast surface.
本研究旨在前瞻性评估颅向乳房移位和铅屏蔽对行冠状动脉 CT 血管造影术的女性体内乳房表面剂量的影响。
54 名女性(平均年龄 59.2 ± 9.8 岁)前瞻性接受冠状动脉 64-MDCT 血管造影检查以评估胸痛。患者随机分为对照组(n = 16)、乳房移位组(n = 22)或乳房移位加铅屏蔽组(n = 16)。将热释光剂量计(TLD)放置在每个乳房象限和双乳乳晕区域的表面。比较组间乳房表面剂量、乳房移位程度和冠状动脉图像质量。进行了体模剂量研究以比较胸壁 z 轴定位时的乳房剂量。
共记录了 1620 个 TLD 剂量测量值。与对照组相比,乳房移位组的乳房表面剂量平均降低 23%(24.3 对 18.6 mGy,p = 0.015),乳房移位加铅屏蔽组降低 36%(24.3 对 15.6 mGy,p = 0.0001)。最大的表面剂量降低发生在上外侧象限(单独移位时为 66%,移位加屏蔽时为 63%)、上内侧象限(65%,58%)和乳晕象限(44%,53%)。A 罩杯乳房的表面剂量降低最小:移位组为 7%,移位加铅组为 3%(p = 0.741)。B 罩杯(25%和 56%,p = 0.273)、C 罩杯(38%和 60%,p = 0.001)和 D 罩杯(31%和 25%,p = 0.095)的乳房表面剂量降低较大。大多数患者(79%)的乳房移位要么很好(< 乳房的 50%在扫描范围内),要么很好(< 乳房的 75%在扫描范围内)。组间冠状动脉图像质量无显著差异。体模剂量研究表明,表面 TLD 测量值低估了组织吸收剂量,平均低估 9%,并且颅向乳房移位量与乳房剂量之间存在很强的负相关。
在冠状动脉 CTA 中使用乳房移位可显著降低乳房表面的辐射剂量。